Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page footer revision tag was updated from v3.5.2 to v3.5.3, signaling a minor site update to the template.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter revision tag updated from v3.5.0 to v3.5.2; the previous revision tag is no longer displayed.SummaryDifference0.1%

- Check49 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor site update.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing v3.4.2; this is a minor site maintenance update that does not affect study information.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.4.2 to the site. Removed older notices including the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check99 days agoChange DetectedAdded a government funding notice at the top of the page and updated the site version to v3.4.1, replacing the previous v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.